View Score: An early warning score to detect possible complications among COVID-19 patients.

Autor: Bhakare M; Department of Respiratory Medicine, Symbiosis Medical College for Women and Symbiosis University Hospital and Research Centre, Symbiosis International (Deemed University), Pune, Maharashtra, India., Nikalje R; Symbiosis University Hospital and Research Centre, Symbiosis International (Deemed University), Pune, Maharashtra, India., Patil R; Department of Community Medicine, Symbiosis Medical College for Women, Symbiosis International (Deemed University), Pune, Maharashtra, India., Shukla U; Intensive Care Unit, Symbiosis University Hospital And Research Centre, Symbiosis International (Deemed University), Pune, Maharashtra, India., Bokade R; Department of Emergency Medicine, NKP Salve Institute of Medical Sciences and Lata Mangeshkar Hospital, Nagpur, Maharashtra, India., Sakhare G; BRIOTA Technologies Private Limited Pune, Maharashtra, India., Joshi S; BRIOTA Technologies Private Limited Pune, Maharashtra, India., Pais A; BRIOTA Technologies Private Limited Pune, Maharashtra, India.
Jazyk: angličtina
Zdroj: Journal of family medicine and primary care [J Family Med Prim Care] 2023 Dec; Vol. 12 (12), pp. 3160-3166. Date of Electronic Publication: 2023 Dec 21.
DOI: 10.4103/jfmpc.jfmpc_221_23
Abstrakt: Introduction: Understanding pulmonary function at various phases after coronavirus disease 2019 (COVID-19) infection is critical for determining the exact pathophysiological mechanism of COVID-19.
Research Question: What is the correlation between spirometry indices and clinical indicators in COVID-19 patients over a 6-week follow-up?
Objectives: 1) To assess deterioration or improvement in spirometry parameters including forced vital capacity (FVC), forced expiratory volume in one second (FEV 1 ), and ratio FEV 1 /FVC in COVID-19 patients. 2) To study the correlation between FVC, FEV 1 , and FEV 1 /FVC with oxygen saturation and clinical findings.
Materials and Methods: A prospective observational study was conducted for a 6-week period among 25, COVID-19 patients who were either asymptomatic or mildly symptomatic. Each patient received a home-use-connected spirometer-SpiroPRO ® , a pulse oximeter, and a thermometer from Briota Technologies Pvt Ltd. (BRIOTA). Patients and healthcare professionals were given training for performing spirometry twice a day as well as access to mobile apps was provided. Spirometry indices, patient symptoms, and vital statistics were used to calculate the VIEW™ score using machine learning algorithms.
Result: The Bland-Altman plots showed that FEV 1 reduced slightly up to 21-28 days and comes back to normal around 42 days. VIEW™ score increased up to day 21 and then decreased toward day 42 . An increase in VIEW™ score increases the risk of COVID-19 complications. VIEW™ score and FEV 1 showed a significant correlation.
Conclusion: Home-based spirometry acts as an effective tool for COVID-19 patients to predict lung complications and also promote self-monitoring thereby reducing the burden on the health system.
Competing Interests: There are no conflicts of interest.
(Copyright: © 2023 Journal of Family Medicine and Primary Care.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje